Comparison of effects of bezafibrate and fenofibrate on circulating proprotein convertase subtilisin/kexin type 9 and adipocytokine levels in dyslipidemic subjects with impaired glucose tolerance or type 2 diabetes mellitus: Results from a crossover study

Tohru Noguchi(Kanazawa University), Hiroshi Mabuchi(Kanazawa University), Kunimasa Yagi(University of Ulsan), Rie Oka(Hokuriku Electric Power Company (Japan)), Masako Sugihara(Kanazawa University), Naoto Yamaaki(Kanazawa University), Masa‐aki Kawashiri(Kanazawa University), Akihiro Inazu(Kanazawa University), Atsushi Nohara(Kanazawa University), Masakazu Yamagishi, Hayato Tada(Kanazawa University), Mutsuko Takata(Komatsu (Japan)), Junji Kobayashi(Chiba University), Naoko Ito(University of Tsukuba)
Atherosclerosis
February 23, 2011
Cited by 40


Related Papers